Pfizer Inc. et al v. Apotex Inc. et al
| Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and Wyeth LLC |
| Apotex Inc. and Apotex Corp. |
| Apotex Corp. and Apotex Inc. |
| FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc. and Wyeth LLC |
| 1:2025cv01532 |
| December 18, 2025 |
| U.S. District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 9, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 19
SO ORDERED, re (17 in 1:25-cv-01532-GBW, 18 in 1:25-cv-01306-GBW) STIPULATION and [Proposed] Order to Consolidate filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc. ***ALL PAPERS SHOULD BE FILED IN THE LEAD CASE.*** Signed by Judge Gregory B. Williams on 2/9/2026. Associated Cases: 1:25-cv-01306-GBW, 1:25-cv-01532-GBW(lnb)
|
|
Filing 18
ORAL ORDER: IT IS HEREBY ORDERED that, by no later than March 9, 2026, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (See Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes, any deviations from the applicable form scheduling order, or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order in which those appear. Parties should also send a WORD version of the joint proposed Scheduling Order to [email protected]. ORDERED by Judge Gregory B. Williams on 02/09/26. (lnb)
|
| Filing 17 STIPULATION and [Proposed] Order to Consolidate - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Dellinger, Megan) |
| Case associated with lead case: Create association to 1:25-cv-01306-GBW. (lnb) |
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul, Richard T. Ruzich, Luke T. Shannon and Roshan P. Shrestha filed by Apotex Inc., Apotex Corp. Signed by Judge Gregory B. Williams on 2/9/2026. (lnb)
|
|
SO ORDERED, re (15 in 1:25-cv-01306-GBW, 14 in 1:25-cv-01532-GBW) MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, Christopher J. Mandernach, Andrew L. Hoffman, Ayelet Evrony, Rhochelle Krawetz, and Daniel P. Schneider filed by Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Pfizer Inc. Signed by Judge Gregory B. Williams on 2/6/2026. Associated Cases: 1:25-cv-01306-GBW, 1:25-cv-01532-GBW(lnb)
|
| Filing 16 Pro Hac Vice Fee - Credit Card Payment received for Rhochelle Krawetz and Daniel P. Schneider. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, Christopher J. Mandernach, Andrew L. Hoffman, Ayelet Evrony, Rhochelle Krawetz, and Daniel P. Schneider )( Payment of $ 100, receipt number ADEDC-4893943).(Dellinger, Megan) |
| Filing 15 Pro Hac Vice Fee - Credit Card Payment received for Thomas H.L. Selby, Stanley E. Fisher, Christopher J. Mandernach, Andrew L. Hoffman, and Ayelet Evrony. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, Christopher J. Mandernach, Andrew L. Hoffman, Ayelet Evrony, Rhochelle Krawetz, and Daniel P. Schneider )( Payment of $ 250, receipt number ADEDC-4893937).(Dellinger, Megan) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Thomas H.L. Selby, Stanley E. Fisher, Christopher J. Mandernach, Andrew L. Hoffman, Ayelet Evrony, Rhochelle Krawetz, and Daniel P. Schneider - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (Dellinger, Megan) |
| Filing 13 ANSWER to #9 Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC.(Dellinger, Megan) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Andrew M. Alul, Richard T. Ruzich, Luke T. Shannon, and Roshan P. Shrestha. ( re #11 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul, Richard T. Ruzich, Luke T. Shannon and Roshan P. Shrestha )( Payment of $ 200, receipt number ADEDC-4886295).(Bilson, David) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul, Richard T. Ruzich, Luke T. Shannon and Roshan P. Shrestha - filed by Apotex Corp., Apotex Inc.. (Attachments: #1 Certification of Andrew M. Alul, #2 Certification of Richard T. Ruzich, #3 Certification of Luke T. Shannon, #4 Certification of Roshan P. Shrestha)(Bilson, David) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp.; Corporate Parent Apotex Holdco Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Filing 9 ANSWER to #1 Complaint Additional Defenses, COUNTERCLAIM against All Plaintiffs by Apotex Corp., Apotex Inc..(Phillips, John) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (alb) |
| Filing 8 WAIVER OF SERVICE returned executed by Pfizer Inc., Wyeth LLC, FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V.: For Apotex Corp. waiver sent on 12/19/2025, answer due 2/17/2026. (Dellinger, Megan) |
| Filing 7 WAIVER OF SERVICE returned executed by Pfizer Inc., Wyeth LLC, FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V.: For Apotex Inc. waiver sent on 12/19/2025, answer due 2/17/2026. (Dellinger, Megan) |
| Filing 6 Summons Issued as to Apotex Corp. on 12/19/2025; Apotex Inc. on 12/19/2025. (Attachments: #1 Summons Issued, Apotex Inc.)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC - filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,770,441 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/06/2025. Date of Expiration of Patent: 08/31/2035.Thirty Month Stay Deadline: 5/6/2028. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-4862255) - filed by Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
